9 22.00 (42.52, 0.86) 98 30.71 (46.97, 15.14) 99 five.42 (24.07, 10.37) 78 16.55 (31.31, three.81) 99 17.85 (23.08, 13.02) 99 22.98 (47.31, 1.54) 97 7.29 (16.69, two.54) 95 15.97 (26.34, 6.26) 99 11.09 (21.3, 0.09) 98 12.40 (29.01, six.63) 93 17.27 (45.84, 13.17) 88 1.84 (19.71, 19.57) 60 ten.60 (23.59, 4.53) 94 1.30 (15.15, 13.98) 59 six.23 (33.48, 21.98) 67 9.29 (six.19, 27.22) 9 0.56 (8.41, ten.64) 44 5.06 (29.83, 19.92) 65 10.60 (0.05, 21.84) two 1.85 (9.48, 12.93) 35 15.61 (10.48, 42.08) 11 6.93 (19.51, 33.04) 30 8.73 (23.05, 4.56) 93 Comparator Placebo 0 MTX 14.71 (3.85, 33.43) five 0 aTNF 20.17 (12.33, 29.73) 1 5.42 (10.37, 24.07) 22 0 Tocilizumab 31.28 (18.69, 45.21) 1 16.55 (three.81, 31.31) 1 11.09 (0.09, 21.3) two 0 aTNF MTX 32.53 (13.46, 52.09) 1 17.85 (13.02, 23.08) 1 12.40 (six.63, 29.01) 7 1.30 (13.98, 15.15) 41 0 Abatacept MTX 37.63 (6.71, 67.22) 1 22.98 (1.54, 47.31) three 17.27 (13.17, 45.84) 12 six.23 (21.98, 33.48) 33 five.06 (19.92, 29.83) 35 0 Anakinra MTX
9 22.00 (42.52, 0.86) 98 30.71 (46.97, 15.14) 99 five.42 (24.07, 10.37) 78 16.55 (31.31, 3.81) 99 17.85 (23.08, 13.02) 99 22.98 (47.31, 1.54) 97 7.29 (16.69, two.54) 95 15.97…